InterCure Ltd. – NASDAQ:INCR
InterCure Ltd. stock price today
$1.645
+0.01
+0.92%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 16 hours
InterCure Ltd. stock price monthly change
-34.27%
month
InterCure Ltd. stock price quarterly change
-34.27%
quarter
InterCure Ltd. stock price yearly change
+30.40%
year
InterCure Ltd. key metrics
Market Cap | 78.25M |
Enterprise value | 92.1M |
P/E | 8.36 |
EV/Sales | 0.27 |
EV/EBITDA | 2.34 |
Price/Sales | 1.07 |
Price/Book | 0.72 |
PEG ratio | 0.07 |
EPS | -1.38 |
Revenue | 355.55M |
EBITDA | 7.84M |
Income | -62.08M |
Revenue Q/Q | -30.43% |
Revenue Y/Y | -8.52% |
Profit margin | 4.83% |
Oper. margin | 15.12% |
Gross margin | 43.14% |
EBIT margin | 15.12% |
EBITDA margin | 2.21% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeInterCure Ltd. stock price history
InterCure Ltd. stock forecast
InterCure Ltd. financial statements
| Mar 2023 | 106.17M | 92K | 0.09% |
|---|---|---|---|
| Jun 2023 | 102.43M | 4.88M | 4.77% |
| Sep 2023 | 73.46M | -33.52M | -45.64% |
| Dec 2023 | 73.46M | -33.52M | -45.64% |
| 2022-08-15 | 0.26 | 0.34 |
|---|---|---|
| 2022-11-15 | 0.32 | 0.16 |
| 2023-05-15 | 0.08 | 0.01 |
| Mar 2023 | 875679000 | 352.70M | 40.28% |
|---|---|---|---|
| Jun 2023 | 841845000 | 314.19M | 37.32% |
| Sep 2023 | 786614000 | 329.55M | 41.9% |
| Dec 2023 | 786614000 | 329.55M | 41.9% |
| Mar 2023 | -52.53M | -14.42M | -59.35M |
|---|---|---|---|
| Jun 2023 | 949K | 0 | 0 |
| Sep 2023 | 0 | 0 | 0 |
| Dec 2023 | 0 | 0 | 0 |
InterCure Ltd. alternative data
| Aug 2023 | 370 |
|---|---|
| Sep 2023 | 370 |
| Oct 2023 | 370 |
| Nov 2023 | 370 |
| Dec 2023 | 370 |
| Jan 2024 | 370 |
| Feb 2024 | 370 |
| Mar 2024 | 370 |
| Apr 2024 | 370 |
| May 2024 | 370 |
| Jun 2024 | 270 |
| Jul 2024 | 270 |
InterCure Ltd. other data
8.69%
+1.03%
of INCR is owned by hedge funds
3.93M
+992.54K
shares is hold by hedge funds
| Quarter | Transcript |
|---|---|
| Q4 2022 4 Apr 2023 | Q4 2022 Earnings Call Transcript |
| Q2 2022 16 Aug 2022 | Q2 2022 Earnings Call Transcript |
| Q1 2022 17 May 2022 | Q1 2022 Earnings Call Transcript |
| Q3 2021 16 Nov 2021 | Q3 2021 Earnings Call Transcript |
InterCure: Bargain Israel Cannabis Play
InterCure: Leader In Israel's Growing Medical Cannabis Market
InterCure: How Bright Is The Company's Future In 2023
InterCure: Why The Company Is Grossly Undervalued By Wall Street
Buy InterCure To Ride The Coming Wave Of Global Cannabis Growth
InterCure: Highlighting A Profitable Israeli Cannabis Operator
InterCure: A Leader In Global Cannabis
InterCure Is Growing In The Massive Global Cannabis Market
IntureCure: Israel Recreation Cannabis Boom On The Way
-
What's the price of InterCure Ltd. stock today?
One share of InterCure Ltd. stock can currently be purchased for approximately $1.65.
-
When is InterCure Ltd.'s next earnings date?
Unfortunately, InterCure Ltd.'s (INCR) next earnings date is currently unknown.
-
Does InterCure Ltd. pay dividends?
No, InterCure Ltd. does not pay dividends.
-
How much money does InterCure Ltd. make?
InterCure Ltd. has a market capitalization of 78.25M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 8.52% to 355.55M US dollars. InterCure Ltd. made a loss 61.96M US dollars in net income (profit) last year or $0.01 on an earnings per share basis.
-
What is InterCure Ltd.'s stock symbol?
InterCure Ltd. is traded on the NASDAQ under the ticker symbol "INCR".
-
What is InterCure Ltd.'s primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of InterCure Ltd.?
Shares of InterCure Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does InterCure Ltd. have?
As Jul 2024, InterCure Ltd. employs 270 workers, which is 27% less then previous quarter.
-
When InterCure Ltd. went public?
InterCure Ltd. is publicly traded company for more then 6 years since IPO on 28 Jan 2019.
-
What is InterCure Ltd.'s official website?
The official website for InterCure Ltd. is intercure.co.
-
How can i contact InterCure Ltd.?
InterCure Ltd. can be reached via phone at +972 77 460 5012.
InterCure Ltd. company profile:
InterCure Ltd.
intercure.coExchange:
NASDAQ
Full time employees:
270
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.
85 Medinat ha-Yehudim Street
Herzliya, 4676670
Herzliya, 4676670
CIK: 0001857030
ISIN: IL0011063760
CUSIP: M549GJ111
